MCL1 and breast carcinoma: Previous reports have shown that bufalin enhanced TRAIL-induced apoptosis in MCF-7 and MDA-MB-231 breast cancer cells by activating the extrinsic apoptotic pathway [39], the downregulation of Cbl [40] and the inhibition of STAT3/Mcl-1 [41].